Halofuginone hydrobromide
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Halofuginone hydrobromide, covering 2012-07-24 to 2013-06-05. Get the full timeline:
Most recent: Clinical Trial Update: Halofuginone Hydrobromide in Treating Patients With HIV-Related Kaposi's Sarcoma [Phase 2]